Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals

Fig. 1

CSF Aβ42 and Aβ40 in non-AD and AD populations. CSF concentration of Aβ42 (a) and Aβ40 (b) in four independent cohorts (Montpellier 1 (Mtp-1), Montpellier 2 (Mtp-2), Paris, SPIN-Barcelona) confirmed the significant difference between NAD and AD patients for both analytes (t test). Differences in CSF Aβ40 measured in two ADNI cohorts (c) were also significant between ADNI(+) and ADNI(−) patients stratified using the PLM scale (see the “Methods” section). Note that Aβ has been assessed using five different detection methods (supTable 1)

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193